MedPath

SFHF 202

SFHF 202

Discontinued
DIN Number

02238164

Drug Class

Human

Market Date

Oct 28, 1998

Company
HC

beaumont bio-med inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02238164
AIG Number0333800001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationSublingual
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (3)

APIS MELLIFICAActive
Strength: 12 X
Monograph: APIS MELLIFICA
LAC VACCINUMActive
Strength: 30 X
Monograph: LAC VACCINUM
LACTIC ACIDActive
Strength: 6 X
Monograph: LACTIC ACID

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.